Delcath sets outlook amid plans to enter National Medicaid Drug Rebate Agreement

Stock Information for Delcath Systems Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Delcath Systems Inc.

Delcath Systems Issues Full Year 2025 Guidance
Delcath Systems to Participate at the Craig-Hallum 22nd Annual Investor Conference
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Delcath Systems Reports First Quarter 2025 Results and Business Highlights
Delcath Systems Announces FDA Clearance of IND Application for Phase 2 Clinical Trial of HEPZATO(TM) in Liver-Dominant Metastatic Breast Cancer
Delcath Systems to Host First Quarter 2025 Earnings Call
Delcath Systems Announces Publication of Comparative Analysis from Randomized Portion of FOCUS Study in Metastatic Uveal Melanoma
Beta Bionics Announces Board Appointment of Gerard Michel

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.